Concepedia

Swati Gupta

SG

7

Publications

707

Citations

7

H-Index

2017

Active since

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Vanderbilt University

Swati Gupta is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, drug development, and pharmacology.

Top concepts

MedicinePharmacologyDrug DevelopmentMolecular BiologyBiochemistryDrug DiscoveryPharmacotherapyNatural SciencesMedicinal ChemistryGenetics

Publications per year

2017–2023

7

Publications

7

Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates

Christopher R. Brown, Swati Gupta, June Qin et al. · Nucleic Acids Research · 2020 · 265 citations · Full text

Sirna Accumulation, Molecular Pharmacology, Medicinal Chemistry +15

Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates

Jayaprakash K. Nair, Husain Attarwala, Alfica Sehgal et al. · Nucleic Acids Research · 2017 · 258 citations · Full text

Pharmaceutical Science, Molecular Biology, Gene Delivery +16

Reversal of siRNA-mediated gene silencing in vivo

Ivan Zlatev, Adam Castoreno, Christopher R. Brown et al. · Nature Biotechnology · 2018 · 92 citations

Genetics, Antisense Therapy, Small Rna +5

RT-qPCR Methods to Support Pharmacokinetics and Drug Mechanism of Action to Advance Development of RNAi Therapeutics

Elena Castellanos-Rizaldos, Christopher R. Brown, Sean Dennin et al. · Nucleic Acid Therapeutics · 2020 · 27 citations · Full text

Bioorganic Chemistry, Engineering, Molecular Biology +21

Metabolically Stable Anomeric Linkages Containing GalNAc–siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways

Kandasamy Pachamuthu, S. Mori, Shigeo Matsuda et al. · Journal of Medicinal Chemistry · 2023 · 27 citations

Rows per page

1–5 of 7